Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 386

1.

A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.

Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR.

J Appl Microbiol. 2006 Apr;100(4):754-64.

2.

The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics.

Burton JP, Chilcott CN, Tagg JR.

Oral Dis. 2005;11 Suppl 1:29-31. Review.

PMID:
15752094
3.

Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour.

Masdea L, Kulik EM, Hauser-Gerspach I, Ramseier AM, Filippi A, Waltimo T.

Arch Oral Biol. 2012 Aug;57(8):1041-7. doi: 10.1016/j.archoralbio.2012.02.011. Epub 2012 Mar 10.

PMID:
22405584
4.
5.

Comparative effects of different chlorhexidine mouth-rinse formulations on volatile sulphur compounds and salivary bacterial counts.

Roldán S, Herrera D, Santa-Cruz I, O'Connor A, González I, Sanz M.

J Clin Periodontol. 2004 Dec;31(12):1128-34.

PMID:
15560817
7.
8.

Effects of oil drops containing Lactobacillus salivarius WB21 on periodontal health and oral microbiota producing volatile sulfur compounds.

Suzuki N, Tanabe K, Takeshita T, Yoneda M, Iwamoto T, Oshiro S, Yamashita Y, Hirofuji T.

J Breath Res. 2012 Mar;6(1):017106. doi: 10.1088/1752-7155/6/1/017106. Epub 2012 Feb 27.

PMID:
22368259
9.
10.

Safety assessment of the oral cavity probiotic Streptococcus salivarius K12.

Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR.

Appl Environ Microbiol. 2006 Apr;72(4):3050-3.

11.

Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: an open-label pilot trial.

Iwamoto T, Suzuki N, Tanabe K, Takeshita T, Hirofuji T.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Aug;110(2):201-8. doi: 10.1016/j.tripleo.2010.03.032.

PMID:
20659698
12.

Effects of herbal mouthwash containing the pericarp extract of Garcinia mangostana L on halitosis, plaque and papillary bleeding index.

Rassameemasmaung S, Sirikulsathean A, Amornchat C, Hirunrat K, Rojanapanthu P, Gritsanapan W.

J Int Acad Periodontol. 2007 Jan;9(1):19-25.

PMID:
17274236
13.

The efficacy of two oral hygiene regimens in reducing oral malodour: a randomised clinical trial.

Feres M, Figueiredo LC, Faveri M, Guerra MC, Mateo LR, Stewart B, Williams M, Panagakos F.

Int Dent J. 2015 Dec;65(6):292-302. doi: 10.1111/idj.12183. Epub 2015 Sep 24.

PMID:
26404947
14.
15.

Management of oral malodour.

Quirynen M.

J Clin Periodontol. 2003;30 Suppl 5:17-8.

PMID:
12787198
16.

Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.

Burton JP, Wescombe PA, Macklaim JM, Chai MH, Macdonald K, Hale JD, Tagg J, Reid G, Gloor GB, Cadieux PA.

PLoS One. 2013 Jun 13;8(6):e65991. doi: 10.1371/journal.pone.0065991. Print 2013.

17.
18.

Effect of chewing gums containing the probiotic bacterium Lactobacillus reuteri on oral malodour.

Keller MK, Bardow A, Jensdottir T, Lykkeaa J, Twetman S.

Acta Odontol Scand. 2012 May;70(3):246-50. doi: 10.3109/00016357.2011.640281. Epub 2011 Dec 20.

PMID:
22182258
19.

A study of triclosan and its solubilizers as inhibitors of oral malodour.

Young A, Jonski G, Rölla G.

J Clin Periodontol. 2002 Dec;29(12):1078-81.

PMID:
12492907
20.

Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study.

Burton JP, Cowley S, Simon RR, McKinney J, Wescombe PA, Tagg JR.

Food Chem Toxicol. 2011 Sep;49(9):2356-64. doi: 10.1016/j.fct.2011.06.038. Epub 2011 Jun 21.

PMID:
21722694

Supplemental Content

Support Center